<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
    <front>
        <journal-meta>
            <journal-id></journal-id>
            <issn></issn>
        </journal-meta>
        <article-meta>
            <title-group>
                <article-title></article-title>
            </title-group>
            <pub-date>
                <year></year>
            </pub-date>
        </article-meta> 
    </front>
    <back>
        <ref-list>
            <ref id="b1">
                <label>1. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sugarman</surname>
                            <given-names>EA</given-names>
                        </name>, 
                        <name>
                            <surname>Nagan</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Zhu</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Akmaev</surname>
                            <given-names>VR</given-names>
                        </name>, 
                        <name>
                            <surname>Zhou</surname>
                            <given-names>Z</given-names>
                        </name>, 
                        <name>
                            <surname>Rohlfs</surname>
                            <given-names>EM</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of &gt;72,400 specimens</article-title>. 
                    <source>Eur J Hum Genet</source>. 
                    <year>2012</year>
                    <month>Jan</month>;
                    <volume>20</volume>(
                    <issue>1</issue>):
                    <fpage>27</fpage>–
                    <lpage>32</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/ejhg.2011.134</pub-id>
                    <pub-id pub-id-type="pmid">21811307</pub-id>
                    <issn>1018-4813</issn>
                </mixed-citation>
            </ref>
            <ref id="b2">
                <label>2. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Koul</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Al-Futaisi</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Al-Thihli</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Bruwer</surname>
                            <given-names>Z</given-names>
                        </name>, 
                        <name>
                            <surname>Scott</surname>
                            <given-names>P</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Segmental Spinal Muscular Atrophy Localised to the Lower Limbs: first case from Oman</article-title>. 
                    <source>Sultan Qaboos Univ Med J</source>. 
                    <year>2017</year>
                    <month>Aug</month>;
                    <volume>17</volume>(
                    <issue>3</issue>):
                    <fpage>e355</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.18295/squmj.2017.17.03.018</pub-id>
                    <pub-id pub-id-type="pmid">29062563</pub-id>
                    <issn>2075-051X</issn>
                </mixed-citation>
            </ref>
            <ref id="b3">
                <label>3. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lunn</surname>
                            <given-names>MR</given-names>
                        </name>, 
                        <name>
                            <surname>Wang</surname>
                            <given-names>CH</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Spinal muscular atrophy</article-title>. 
                    <source>Lancet</source>. 
                    <year>2008</year>
                    <month>Jun</month>;
                    <volume>371</volume>(
                    <issue>9630</issue>):
                    <fpage>2120</fpage>–
                    <lpage>33</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(08)60921-6</pub-id>
                    <pub-id pub-id-type="pmid">18572081</pub-id>
                    <issn>0140-6736</issn>
                </mixed-citation>
            </ref>
            <ref id="b4">
                <label>4. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zanetta</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Riboldi</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Nizzardo</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Simone</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Faravelli</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Bresolin</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)</article-title>. 
                    <source>J Cell Mol Med</source>. 
                    <year>2014</year>
                    <month>Feb</month>;
                    <volume>18</volume>(
                    <issue>2</issue>):
                    <fpage>187</fpage>–
                    <lpage>96</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/jcmm.12224</pub-id>
                    <pub-id pub-id-type="pmid">24400925</pub-id>
                    <issn>1582-1838</issn>
                </mixed-citation>
            </ref>
            <ref id="b5">
                <label>5. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Arnold</surname>
                            <given-names>WD</given-names>
                        </name>, 
                        <name>
                            <surname>Kassar</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Kissel</surname>
                            <given-names>JT</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Spinal muscular atrophy: diagnosis and management in a new therapeutic era</article-title>. 
                    <source>Muscle Nerve</source>. 
                    <year>2015</year>
                    <month>Feb</month>;
                    <volume>51</volume>(
                    <issue>2</issue>):
                    <fpage>157</fpage>–
                    <lpage>67</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/mus.24497</pub-id>
                    <pub-id pub-id-type="pmid">25346245</pub-id>
                    <issn>0148-639X</issn>
                </mixed-citation>
            </ref>
            <ref id="b6">
                <label>6. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Verhaart</surname>
                            <given-names>IE</given-names>
                        </name>, 
                        <name>
                            <surname>Robertson</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Wilson</surname>
                            <given-names>IJ</given-names>
                        </name>, 
                        <name>
                            <surname>Aartsma-Rus</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Cameron</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Jones</surname>
                            <given-names>CC</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review</article-title>.
                    <source>Orphanet J Rare Dis</source>. 
                    <year>2017</year>
                    <month>Jul</month>;
                    <volume>12</volume>(
                    <issue>1</issue>):
                    <fpage>124</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s13023-017-0671-8</pub-id>
                    <pub-id pub-id-type="pmid">28676062</pub-id>
                    <issn>1750-1172</issn>
                </mixed-citation>
            </ref>
            <ref id="b7">
                <label>7. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kolb</surname>
                            <given-names>SJ</given-names>
                        </name>, 
                        <name>
                            <surname>Kissel</surname>
                            <given-names>JT</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Spinal Muscular Atrophy</article-title>. 
                    <source>Neurol Clin</source>. 
                    <year>2015</year>
                    <month>Nov</month>;
                    <volume>33</volume>(
                    <issue>4</issue>):
                    <fpage>831</fpage>–
                    <lpage>46</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.ncl.2015.07.004</pub-id>
                    <pub-id pub-id-type="pmid">26515624</pub-id>
                    <issn>0733-8619</issn>
                </mixed-citation>
            </ref>
            <ref id="b8">
                <label>8. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Finkel</surname>
                            <given-names>RS</given-names>
                        </name>, 
                        <name>
                            <surname>Mercuri</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Darras</surname>
                            <given-names>BT</given-names>
                        </name>, 
                        <name>
                            <surname>Connolly</surname>
                            <given-names>AM</given-names>
                        </name>, 
                        <name>
                            <surname>Kuntz</surname>
                            <given-names>NL</given-names>
                        </name>, 
                        <name>
                            <surname>Kirschner</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>ENDEAR Study Group</collab>
                    </person-group>. 
                    <article-title>Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2017</year>
                    <month>Nov</month>;
                    <volume>377</volume>(
                    <issue>18</issue>):
                    <fpage>1723</fpage>–
                    <lpage>32</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1702752</pub-id>
                    <pub-id pub-id-type="pmid">29091570</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
            </ref>
            <ref id="b9">
                <label>9. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>De Vivo</surname>
                            <given-names>DC</given-names>
                        </name>, 
                        <name>
                            <surname>Hwu</surname>
                            <given-names>WL</given-names>
                        </name>, 
                        <name>
                            <surname>Reyna</surname>
                            <given-names>SP</given-names>
                        </name>, 
                        <name>
                            <surname>Farwell</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Gheuens</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Sun</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Interim Efficacy and Safety Results from the Phase 2 NURTURE Study Evaluating Nusinersen in Presymptomatic Infants with Spinal Muscular Atrophy (S46.003)</article-title>.
                    <source>Neurology</source>. 
                    <year>2017</year>
                    <month>Apr</month>;
                    <volume>88</volume>(
                    <issue>16</issue>
                    <supplement>Supplement</supplement>):
                    <fpage>S46.003</fpage>.
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
            <ref id="b10">
                <label>10. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mercuri</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Darras</surname>
                            <given-names>BT</given-names>
                        </name>, 
                        <name>
                            <surname>Chiriboga</surname>
                            <given-names>CA</given-names>
                        </name>, 
                        <name>
                            <surname>Day</surname>
                            <given-names>JW</given-names>
                        </name>, 
                        <name>
                            <surname>Campbell</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Connolly</surname>
                            <given-names>AM</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>CHERISH Study Group</collab>
                    </person-group>. 
                    <article-title>Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2018</year>
                    <month>Feb</month>;
                    <volume>378</volume>(
                    <issue>7</issue>):
                    <fpage>625</fpage>–
                    <lpage>35</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1710504</pub-id>
                    <pub-id pub-id-type="pmid">29443664</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
            </ref>
            <ref id="b11">
                <label>11. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chiriboga</surname>
                            <given-names>CA</given-names>
                        </name>, 
                        <name>
                            <surname>Swoboda</surname>
                            <given-names>KJ</given-names>
                        </name>, 
                        <name>
                            <surname>Darras</surname>
                            <given-names>BT</given-names>
                        </name>, 
                        <name>
                            <surname>Iannaccone</surname>
                            <given-names>ST</given-names>
                        </name>, 
                        <name>
                            <surname>Montes</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>De Vivo</surname>
                            <given-names>DC</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy</article-title>. 
                    <source>Neurology</source>. 
                    <year>2016</year>
                    <month>Mar</month>;
                    <volume>86</volume>(
                    <issue>10</issue>):
                    <fpage>890</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1212/WNL.0000000000002445</pub-id>
                    <pub-id pub-id-type="pmid">26865511</pub-id>
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
            <ref id="b12">
                <label>12. </label>
                <mixed-citation publication-type="webpage">
                    <!--person-group><name><surname></surname></name></person-group>.-->
                    <person-group person-group-type="author"> 
                        <collab>Modra jagoda d.o.o.</collab>  
                    </person-group> 
                    <source>Register zdravil</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-04-15">cited 2019 apr 17</date-in-citation>].
                    <comment>Available from: <uri>https://mediately.co/si/</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b13">
                <label>13. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pechmann</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Langer</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Schorling</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Stein</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Vogt</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Schara</surname>
                            <given-names>U</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany</article-title>. 
                    <source>J Neuromuscul Dis</source>. 
                    <year>2018</year>;
                    <volume>5</volume>(
                    <issue>2</issue>):
                    <fpage>135</fpage>–
                    <lpage>43</lpage>. 
                    <pub-id pub-id-type="doi">10.3233/JND-180315</pub-id>
                    <pub-id pub-id-type="pmid">29689734</pub-id>
                    <issn>2214-3599</issn>
                </mixed-citation>
            </ref>
            <ref id="b14">
                <label>14. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Glanzman</surname>
                            <given-names>AM</given-names>
                        </name>, 
                        <name>
                            <surname>Mazzone</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Main</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Pelliccioni</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Wood</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Swoboda</surname>
                            <given-names>KJ</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability</article-title>. 
                    <source>Neuromuscul Disord</source>. 
                    <year>2010</year>
                    <month>Mar</month>;
                    <volume>20</volume>(
                    <issue>3</issue>):
                    <fpage>155</fpage>–
                    <lpage>61</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.nmd.2009.11.014</pub-id>
                    <pub-id pub-id-type="pmid">20074952</pub-id>
                    <issn>0960-8966</issn>
                </mixed-citation>
            </ref>
            <ref id="b15">
                <label>15. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>De Sanctis</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Coratti</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Pasternak</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Montes</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Pane</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Mazzone</surname>
                            <given-names>ES</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Developmental milestones in type I spinal muscular atrophy</article-title>. 
                    <source>Neuromuscul Disord</source>. 
                    <year>2016</year>
                    <month>Nov</month>;
                    <volume>26</volume>(
                    <issue>11</issue>):
                    <fpage>754</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.nmd.2016.10.002</pub-id>
                    <pub-id pub-id-type="pmid">27769560</pub-id>
                    <issn>0960-8966</issn>
                </mixed-citation>
            </ref>
            <ref id="b16">
                <label>16. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Crawford</surname>
                            <given-names>TO</given-names>
                        </name>, 
                        <name>
                            <surname>Paushkin</surname>
                            <given-names>SV</given-names>
                        </name>, 
                        <name>
                            <surname>Kobayashi</surname>
                            <given-names>DT</given-names>
                        </name>, 
                        <name>
                            <surname>Forrest</surname>
                            <given-names>SJ</given-names>
                        </name>, 
                        <name>
                            <surname>Joyce</surname>
                            <given-names>CL</given-names>
                        </name>, 
                        <name>
                            <surname>Finkel</surname>
                            <given-names>RS</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study</article-title>. 
                    <source>PLoS ONE</source>. 
                    <year>2012</year>;
                    <volume>7</volume>(
                    <issue>4</issue>):
                    <fpage>e33572</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0033572</pub-id>
                    <pub-id pub-id-type="pmid">22558076</pub-id>
                    <issn>1932-6203</issn>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>
